Abstract: Compounds of formula (I) or their enantiomers, diastereoisomers thereof and the addition salts thereof with pharmaceutically acceptable bases or acids, for use for the prevention or treatment, preferably treatment, of NASH.
Abstract: The present disclosure relates to a composition including, in combination, metformin or a salt thereof, a pharmaceutically acceptable carrier or excipient and at least one compound of formula (I), or the enantiomers, diastereoisomers or pharmaceutically acceptable salts thereof. Formula (I) is as follows: The present disclosure also relates to the use of this composition for the treatment of diseases associated with insulin resistance syndrome.
Abstract: The present invention relates to a composition comprising, in combination, metformin or a salt thereof, a pharmaceutically acceptable carrier or excipient and at least one compound of formula (I), the enantiomers, diastereoisomers or pharmaceutically acceptable salts thereof. Formula (I). The present invention also relates to the use of said composition for the treatment of diseases associated with insulin resistance syndrome.
Abstract: The invention relates to a compound of formula (I), where R1, R2, R7, m, n, and L1 are as defined in claim 1, and to the methods for preparing same, to the pharmaceutical compositions containing same, and to the uses thereof in the treatment of diseases associated with insulin resistance syndrome.
Type:
Grant
Filed:
June 22, 2012
Date of Patent:
October 6, 2015
Assignee:
METABOLYS
Inventors:
Gerard Moinet, Gabriel Baverel, Remi Nazaret, Bernard Ferrier
Abstract: Disclosed herein are compounds and compositions useful in the treatment of pathologies associated with the insulin resistance syndrome (or syndrome X), in particular in the treatment of type 2 diabetes.
Type:
Grant
Filed:
June 22, 2012
Date of Patent:
October 6, 2015
Assignee:
METABOLYS
Inventors:
Gerard Moinet, Gabriel Baverel, Remi Nazaret, Bernard Ferrier
Abstract: The invention relates to a compound of formula (I), where R1, R2, R7, m, n, and L1 are as defined in claim 1, and to the methods for preparing same, to the pharmaceutical compositions containing same, and to the uses thereof in the treatment of diseases associated with insulin resistance syndrome.
Type:
Application
Filed:
June 22, 2012
Publication date:
August 21, 2014
Applicant:
Metabolys
Inventors:
Gerard Moinet, Gabriel Baverel, Remi Nazaret, Bernard Ferrier
Abstract: The invention relates to a compound of formula (I), where R1, R2, R3, m, n, and L1 are as defined in claim 1, to the methods for preparing same, to the pharmaceutical compositions containing same, and to the uses thereof in the treatment of diseases associated with insulin resistance syndrome.
Type:
Application
Filed:
June 22, 2012
Publication date:
June 5, 2014
Applicant:
Metabolys
Inventors:
Gerard Moinet, Gabriel Baverel, Remi Nazaret, Bernard Ferrier